
Optieum Biotechnologies
Developer of antibody-based therapies designed to help in the treatment of patients with cancers. The company's therapies facilitate the development and detection of single-chain variable CAR-T cells ...
Valuation
$0
Share Price
N/A
Total Raised
$11.4M
Last Round
N/A